Zenas BioPharma (ZBIO) Exchange Rate Effect (2023 - 2026)
Zenas BioPharma (ZBIO) recorded quarterly Exchange Rate Effect of -$311000.0 in Q1 2026, down 2927.27% quarter-over-quarter from $11000.0 in Q4 2025, and down 498.08% on a YoY basis from $78125.6 in Q1 2025.
Zenas BioPharma (ZBIO) Exchange Rate Effect (2023 - 2026) Analysis & Trends
Zenas BioPharma's Exchange Rate Effect history runs 4 years deep, the most recent figure standing at -$311000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 498.08% year-over-year to -$311000.0; the TTM figure through Mar 2026 stood at -$511000.0 (down 840.58% YoY), while the FY2025 annual figure was -$252000.0, down 260.51% from the prior year.
- Exchange Rate Effect was -$311000.0 for Q1 2026 at Zenas BioPharma, down from $11000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $141000.0 in Q4 2024 to a low of -$311000.0 in Q1 2026.
- Historically, Exchange Rate Effect has averaged -$49300.0 across 4 years, with a median of -$20500.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Exchange Rate Effect soared 262.07% in 2024, then tumbled 837.5% in 2025.
- A 4-year view of Exchange Rate Effect shows it stood at -$87000.0 in 2023, then jumped by 262.07% to $141000.0 in 2024, then plunged by 92.2% to $11000.0 in 2025, then plunged by 2927.27% to -$311000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$311000.0 (Q1 2026), $11000.0 (Q4 2025), and $25000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Zenas BioPharma | 1.10 Bn | 379.43 Mn | - | -311,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -311,000.00 |
| Mar 31, 2026 | -311,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Jun 30, 2025 | -236,000.00 |
| Jun 30, 2025 | -236,000.00 |
| Mar 31, 2025 | -52,000.00 |
| Mar 31, 2025 | -52,000.00 |
| Dec 31, 2024 | 141,000.00 |
| Dec 31, 2024 | 141,000.00 |
| Sep 30, 2024 | -52,000.00 |
| Sep 30, 2024 | -52,000.00 |
| Jun 30, 2024 | 32,000.00 |
| Jun 30, 2024 | 32,000.00 |
| Mar 31, 2024 | 36,000.00 |
| Mar 31, 2024 | 36,000.00 |
| Dec 31, 2023 | -87,000.00 |
| Dec 31, 2023 | -87,000.00 |